Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00864682 · ClinicalTrials.gov registry record · Phase 4

Preventing Propofol-associated Injection Pain

A Phase 4 study of Pain, sponsored by Benaroya Research Institute.

Completed
Registry status
Phase 4
Development phase
156
Enrollment target
1
Study location

NCT00864682 is a Phase 4 study of Pain that has completed, run by Benaroya Research Institute. The registered enrollment target is 156 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00864682, a Phase 4 study of Pain, has completed, sponsored by Benaroya Research Institute.

COMPLETED
Registry status
Phase 4
Development phase
156 participants
Enrollment target
1
Study location

Study Summary

Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with propofol will be superior to lidocaine administered directly into the vein, under tourniquet control, prior to injection of propofol. Both groups are expected to be superior to placebo.

Conditions Studied

Interventions

  • DRUG Saline
  • DRUG Lidocaine / propofol admixture
  • DRUG lidocaine pretreatment

Study Locations (1)

Washington

  • Benaroya Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2008-01
Est. Completion 2009-04
Phase Phase 4

Sponsor

Benaroya Research Institute

28 total trials

What the Registry Record Tells You About NCT00864682

The ClinicalTrials.gov registry entry for NCT00864682 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (49% lower). The listed sponsor is Benaroya Research Institute, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.

NCT00864682 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00864682 about?

NCT00864682 is a clinical study titled "Preventing Propofol-associated Injection Pain". Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with propofol will be superior to lidocaine adm...

What is the current status of trial NCT00864682?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2008-01. Estimated completion is 2009-04.

What conditions does trial NCT00864682 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00864682?

The interventions under investigation include: Saline (DRUG), Lidocaine / propofol admixture (DRUG), lidocaine pretreatment (DRUG).

Who is sponsoring clinical trial NCT00864682?

This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00864682 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.